Ledger.Open graph →
SEC Form D · filed January 26, 2021

Aditx Therapeutics, Inc

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MOUNTAIN VIEW, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Corinne Pankovcin · Mountain View, CAExecShahrokh Shabahang · Mountain View, CAExec · DirectorRowena Albanna · Mountain View, CAExecBrian E. Brady · Mountain View, CADirectorNamvar E. Kiaie · Mountain View, CADirectorAmro Albanna · Riverside, CAExec · DirectorLaura E. Anthony · Mountain View, CADirectorJeffrey W. Runge · Annapolis, MDDirectorCorinne Pankovcin · Mountain View, CAExecShahrokh Shabahang · REDLANDS, CAExec · DirectorAmro Albanna · Riverside, CAExec · DirectorRowena Albanna · Riverside, CAExecLaura E. Anthony · Mountain View, CADirectorBrian E. Brady · Mountain View, CADirectorNamvar E. Kiaie · Mountain View, CADirectorJeffrey W. Runge · RALEIGH, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗